A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine

Vaccine

Volumn 23, Issue 46-47, 2005, Pages 5450-5456

  Sugai, Toshiyuki ^a,b   Mori, Masaaki ^a   Nakazawa, Masatoshi ^a   Ichino, Motohide ^a   Naruto, Takuya ^a   Kobayashi, Naoki ^a   Kobayashi, Yoshinori ^a   Minami, Mutsuhiko ^a   Yokota, Shumpei ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Adjuvant; CpG motif; DPT vaccine; Mouse; Th1 Th2

Indexed keywords

ALUMINUM HYDROXIDE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYNUCLEOTIDE DERIVATIVE; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CPG ISLAND; DIPHTHERIA; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INFECTION PREVENTION; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PROTEIN MOTIF; TETANUS; TH1 CELL; TH2 CELL; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANTIGENS; CPG ISLANDS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPERSENSITIVITY; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTUBATION, GASTROINTESTINAL; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDES; OVALBUMIN; TH1 CELLS; TH2 CELLS;

EID: 27644544886     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.09.041     Document Type: Article

References (48)

1. S. Manmohan, and O. Derek Advances in vaccine adjuvants Nat Biotechnol 17 1999 1075 1081
2. W.W. Alan, and R.W. Stefan Immunological adjuvants in allergy vaccines: Past, present and future Allergol Int 50 2001 295 301
3. F.M. Audibert, and L.D. Lise Adjuvants: Current status, clinical perspective and future prospects Immunol Today 14 1993 281 284
4. R. Pauwels, M. Van der Straeten, B. Platteau, and H. Bazin The non-specific enhancement of allergy. I. In vivo effects of Bordetella pertussis vaccine on IgE synthesis Allergy 38 1983 239 246
5. J.M. Brewer, M. Conacher, C.A. Hunter, M. Mohrs, F. Brombacher, and J. Alexander Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling J Immunol 163 1999 6448 6454
6. M.H. Samore, and G.R. Siber Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone Vaccine 14 1996 290 297
7. Y. Maezawa, H. Nakajima, K. Kumano, S. Kubo, H. Karasuyama, and I. Iwamoto Role of IgE in Th2 cell-mediated allergic airway inflammation Int Arch Allergy Immunol 131 Suppl. 1 2003 2 6
8. R.K. Guputa Aluminum compounds as vaccine Adv Drug Delivery Rev 32 1998 155 172
9. D.B. Tumas, B. Chan, W. Werther, T. Wrin, J. Vennari, and N. Desjardin Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization J Allergy Clin Immunol 107 2001 1025 1033
10. C. Bez, R. Schubert, M. Kopp, Y. Ersfeld, M. Rosewich, and J. Kuehr Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis Clin Exp Allergy 34 2004 1079 1085
11. E.H. Relyveld, B. Vizzini, and R.K. Guputa Rational approaches to reduce adverse reactions I man to vaccines containing tetanus and diphtheria toxoids Vaccine 16 1998 1016 1023
12. K. Heeg, and S. Zimmermann CpG DNA as a Th1 trigger Int Arch Allergy Immunol 121 2000 87 97
13. K.M. Murphy, W. Ouyang, S.J. Szabo, N.G. Jacobson, M.L. Guler, and J.D. Gorham T helper differentiation proceeds through Stat1-dependent, Stat4-dependent and Stat4-independent phases Curr Top Microbiol Immunol 238 1999 13 26
14. T. Tokunaga, H. Yamamoto, S. Shimada, H. Abe, T. Fukuda, and Y. Fujisawa Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity J Natl Cancer Inst 72 1984 955 962
15. T. Tokunaga, S. Yamamoto, and K. Namba A synthetic single-stranded DNA, poly(dG,dC), induces interferon-alpha/beta and -gamma, augments natural killer activity, and suppresses tumor growth Jpn J Cancer Res 79 1988 682 686
16. M.D. Halpern, R.J. Kurlander, and D.S. Pisetsky Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha Cell Immunol 167 1996 72 78
17. M. Roman, E. Martin-Orozco, J.S. Goodman, M.D. Nguyen, Y. Sato, and A. Ronaghy Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants Nat Med 3 1997 849 854
18. L. Ningshu, O. Noriko, N. Lin, A. Shizuo, and B.B. Kevin CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells Nat Immunol 4 2003 687 693
19. K.J. Stacey, J.M. Blackwell, and Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major Infect Immun 67 1999 3719 3726
20. T.R. Jones, N. Obaldia 3rd, R.A. Gramzinski, Y. Charoenvit, N. Kolodny, and S. Kitov Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys Vaccine 17 1999 3065 3071
21. K.L. Elkins, T.R. Rhinehart-Jones, S. Stibitz, J.S. Conover, and D.M. Klinman Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria J Immunol 162 1999 2291 2298
22. Z. Moldoveanu, L. Love-Homan, W.Q. Huang, A.M. Krieg, and CpG. DNA a novel immune enhancer for systemic and mucosal immunization with influenza virus Vaccine 16 1998 1216 1224
23. C.L. Brazolot Millan, R. Weeratna, A.M. Krieg, C.A. Siegrist, and H.L. Davis CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice Proc Natl Acad Sci USA 95 1998 15553 15558
24. S.L. Prescott Early origins of allergic disease: a review of processes and influences during early immune development Curr Opin Allergy Clin Immunol 3 2003 125 132
25. E. von Mutius The rising trends in asthma and allergic disease Clin Exp Allergy 28 1998 45 49
26. O. Akiko, and S. Taro Genetic and environmental factors of atopy Allergol Int 51 2002 213 219
27. B. Doe, M. Selby, S. Barnett, J. Baenziger, and C.M. Walker Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells Proc Natl Acad Sci USA 93 1996 8578 8583
28. T. Jakob, P.S. Walker, A.M. Krieg, E. von Stebut, M.C. Udey, and J.C. Vogel Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Th1 responses Int Arch Allergy Immunol 118 1999 457 461
29. H.L. Davis, R. Weeratna, T.J. Waldschmidt, L. Tygrett, J. Schorr, and A.M. Krieg CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen J Immunol 160 1998 870 876
30. M. Sakaguchi, S. Inouye, H. Miyazawa, and S. Tamura Measurement of antigen-specific mouse IgE by a fluorometric reverse (IgE-capture) ELISA J Immunol Methods 116 1989 181 187
31. R.K. Guputa, B.E. Rost, E. Relyveld, and G.R. Siber Adjuvant properties of aluminum and calcium compounds M.F. Powell MJ. Newman Vaccine design: the subunit and adjuvant approach 1995 Plenum Publishing New York 229 248
32. C. Barrios, C. Brandt, M. Berney, P.H. Lambert, and C.A. Siegrist Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects Eur J Immunol 26 1996 2666 2670
33. M. Ryan, L. McCarthy, R. Rappuoli, B.P. Mahon, and K.H. Mills Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28 Int Immunol 10 1998 651 662
34. K.H. Mills, A. Barnard, J. Watkins, and K. Redhead Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model Infect Immun 61 1993 399 410
35. M. Leef, K.L. Elkins, J. Barbic, and R.D. Shahin Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production J Exp Med 191 2000 1841 1852
36. K. Saukkonen, C. Cabellos, M. Burroughs, S. Prasad, and E. Tuomanen Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization J Exp Med 173 1991 1143 1149
37. B.P. Mahon, M.S. Ryan, F. Griffin, and K.H. Mills Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells Infect Immun 64 1996 5295 5301
38. B. Adkins, Y. Bu, and P. Guevara The generation of Th memory in neonates versus adults: prolonged primary Th2 effector function and impaired development of Th1 memory J Immunol 166 2001 918 925
39. J. Kovarik, and C.A. Siegrist Optimization of vaccine responses in early life: the role of delivery systems and immunomodulators Immunol Cell Biol 76 1998 222 236
40. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, and H. Sanjo A Toll-like receptor recognizes bacterial DNA Nature 408 2000 740 745
41. H.L. Davis, I.I. Suparto, R.R. Weeratna, Jumintarto, D.D. Iskandriati, and S.S. Chamzah CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans Vaccine 18 2000 1920 1924
42. A.M. Krieg, A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, and R. Teasdale CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 1995 546 549
43. D.M. Klinman, A.K. Yi, S.L. Beaucage, J. Conover, and A.M. Krieg CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon Proc Natl Acad Sci USA 93 1996 2879 2883
44. A.K. Yi, J.H. Chace, J.S. Cowdery, and A.M. Krieg IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides J Immunol 562 1996 558 564
45. D. Serebrisky, A.A. Teper, C.K. Huang, S.Y. Lee, T.F. Zhang, and B.H. Schofield CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma J Immunol 165 2000 5906 5912
46. B. Bohle, B. Jahn-Schmid, D. Maurer, D. Kraft, and C. Ebner Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro Eur J Immunol 29 1999 2344 2353
47. P. Parronchi, F. Brugnolo, F. Annunziato, C. Manuelli, S. Sampognaro, and C. Mavilia Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors J Immunol 163 1999 5946 5953
48. W. Hou, Y. Wu, S. Sun, M. Shi, Y. Sun, and C. Yang Pertussis toxin enhances Th1 responses by stimulation of dendritic cells J Immunol 170 2003 1728 1736